These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 2439712)

  • 1. Pharmacological erection: diagnosis and treatment applications in 69 patients.
    Nellans RE; Ellis LR; Kramer-Levien D
    J Urol; 1987 Jul; 138(1):52-4. PubMed ID: 2439712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physiology of erection and pharmacological management of impotence.
    Lue TF; Tanagho EA
    J Urol; 1987 May; 137(5):829-36. PubMed ID: 3553617
    [No Abstract]   [Full Text] [Related]  

  • 3. Intracavernous drug-induced erections in the management of male erectile dysfunction: experience with 100 patients.
    Sidi AA; Cameron JS; Duffy LM; Lange PH
    J Urol; 1986 Apr; 135(4):704-6. PubMed ID: 2421014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibrosis of tunica albuginea: complication of long-term intracavernous pharmacological self-injection.
    Hu KN; Burks C; Christy WC
    J Urol; 1987 Aug; 138(2):404-5. PubMed ID: 2439714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How safe is the treatment of impotence with intracavernous autoinjection?
    Zentgraf M; Ludwig G; Ziegler M
    Eur Urol; 1989; 16(3):165-71. PubMed ID: 2663519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Intracavernous injection of vasoactive drugs for treating erectile impotence].
    Yasumoto R; Asakawa M; Kawashima H; Yoshimura R; Maekawa T; Kashiwara N; Tanaka H; Nishio S
    Hinyokika Kiyo; 1988 Feb; 34(2):301-4. PubMed ID: 2454019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experience with triple-drug therapy in a pharmacological erection program.
    Govier FE; McClure RD; Weissman RM; Gibbons RP; Pritchett TR; Kramer-Levien D
    J Urol; 1993 Dec; 150(6):1822-4. PubMed ID: 8230514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracavernous self-injection for impotence: a long-term therapeutic option? Experience in 78 patients.
    Girdley FM; Bruskewitz RC; Feyzi J; Graversen PH; Gasser TC
    J Urol; 1988 Nov; 140(5):972-4. PubMed ID: 3172370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physicochemical stability of papaverine hydrochloride-phentolamine mesylate mixtures used for intracavernous injection: a preliminary evaluation.
    Hadzija BW; Mattocks AM; Stahl GM
    J Urol; 1988 Jul; 140(1):64-5. PubMed ID: 2454330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological treatment of erectile dysfunction after radical prostatectomy.
    Dennis RL; McDougal WS
    J Urol; 1988 Apr; 139(4):775-6. PubMed ID: 3352040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vasoactive intracavernous pharmacotherapy for the treatment of erectile impotence in men with spinal cord injury.
    Sidi AA; Cameron JS; Dykstra DD; Reinberg Y; Lange PH
    J Urol; 1987 Sep; 138(3):539-42. PubMed ID: 2442418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracavernous injection of vasoactive drugs, an alternative for treating impotence in spinal cord injury patients.
    Wyndaele JJ; de Meyer JM; de Sy WA; Claessens H
    Paraplegia; 1986 Oct; 24(5):271-5. PubMed ID: 3774363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Auto-injection of the corpus cavernosum with a vasoactive drug combination for vasculogenic impotence.
    Zorgniotti AW; Lefleur RS
    J Urol; 1985 Jan; 133(1):39-41. PubMed ID: 2578067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Four-drug intracavernous therapy for impotence due to corporeal veno-occlusive dysfunction.
    Montorsi F; Guazzoni G; Bergamaschi F; Ferini-Strambi L; Barbieri L; Rigatti P
    J Urol; 1993 May; 149(5 Pt 2):1291-5. PubMed ID: 7683061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of prolonged or priapistic erections following intracavernosal papaverine therapy.
    Padma-Nathan H; Goldstein I; Krane RJ
    Semin Urol; 1986 Nov; 4(4):236-8. PubMed ID: 3797893
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of persistent penile erection and priapism using terbutaline.
    Shantha TR; Finnerty DP; Rodriquez AP
    J Urol; 1989 Jun; 141(6):1427-9. PubMed ID: 2724442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experience with intracavernosal tri-mixture for the management of neurogenic erectile dysfunction.
    Chao R; Clowers DE
    Arch Phys Med Rehabil; 1994 Mar; 75(3):276-8. PubMed ID: 8129578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Metaraminol--an antidote in corpus cavernosum autoinjection therapy-induced prolonged erection].
    Stief CG; Gilbert P; Wetterhauer U; Bähren W; Thon W; Altwein JE
    Urologe A; 1986 May; 25(3):164-5. PubMed ID: 2426857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostaglandin E1 versus phentolamine/papaverine for the treatment of erectile impotence: a double-blind comparison.
    Lee LM; Stevenson RW; Szasz G
    J Urol; 1989 Mar; 141(3):549-50. PubMed ID: 2918589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of a mixture of papaverine, phentolamine and prostaglandin E1 with other intracavernous injections.
    Meinhardt W; Lycklama à Nijeholt AA; Kropman RF; Vermeij P; Zwartendijk J
    Eur Urol; 1994; 26(4):319-21. PubMed ID: 7713130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.